title: Role of PPARα and HNF4α in stress-mediated alterations in lipid homeostasis.
abstract: Stress is a risk factor for several cardiovascular pathologies. PPARα holds a fundamental role in control of lipid homeostasis by directly regulating genes involved in fatty acid transport and oxidation. Importantly, PPARα agonists are effective in raising HDL-cholesterol and lowering triglycerides, properties that reduce the risk for cardiovascular diseases. This study investigated the role of stress and adrenergic receptor (AR)-related pathways in PPARα and HNF4α regulation and signaling in mice following repeated restraint stress or treatment with AR-antagonists administered prior to stress to block AR-linked pathways. Repeated restraint stress up-regulated Pparα and its target genes in the liver, including Acox, Acot1, Acot4, Cyp4a10, Cyp4a14 and Lipin2, an effect that was highly correlated with Hnf4α. In vitro studies using primary hepatocyte cultures treated with epinephrine or AR-agonists confirmed that hepatic AR/cAMP/PKA/CREB- and JNK-linked pathways are involved in PPARα and HNF4α regulation. Notably, restraint stress, independent of PPARα, suppressed plasma triglyceride levels. This stress-induced effect could be attributed in part to hormone sensitive lipase activation in the white adipose tissue, which was not prevented by the increased levels of perilipin. Overall, this study identifies a mechanistic basis for the modification of lipid homeostasis following stress and potentially indicates novel roles for PPARα and HNF4α in stress-induced lipid metabolism.
authors: Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America. mkonstan@cc.uoi.gr
authors: Maria
authors: M
authors: Konstandi
authors: Yatrik M
authors: YM
authors: Shah
authors: Tsutomu
authors: T
authors: Matsubara
authors: Frank J
authors: FJ
authors: Gonzalez
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D002784:Cholesterol / Q000096:biosynthesis / Q000097:blood; D017353:Gene Deletion; D005938:Glucocorticoids / Q000378:metabolism; D051557:Hepatocyte Nuclear Factor 4 / Q000172:deficiency / Q000235:genetics / Q000378:metabolism*; D022781:Hepatocytes / Q000378:metabolism; D006706:Homeostasis; D050356:Lipid Metabolism; D008297:Male; D051379:Mice; D010084:Oxidation-Reduction; D047493:PPAR alpha / Q000378:metabolism*; D011941:Receptors, Adrenergic / Q000378:metabolism; D011973:Receptors, LDL / Q000378:metabolism; D012149:Restraint, Physical / Q000009:adverse effects; D015398:Signal Transduction; D013315:Stress, Psychological / Q000097:blood / Q000378:metabolism* / Q000473:pathology; D014280:Triglycerides / Q000097:blood / Q000378:metabolism; D015854:Up-Regulation
chemical_list: D015415:Biomarkers; D005938:Glucocorticoids; D051557:Hepatocyte Nuclear Factor 4; C496593:Hnf4a protein, mouse; D047493:PPAR alpha; D011941:Receptors, Adrenergic; D011973:Receptors, LDL; D014280:Triglycerides; D002784:Cholesterol
references: Methods Cell Biol. 1976;13:29-83
references: 177845
references: Mol Cell Biol. 1995 Jun;15(6):3012-22
references: 7539101
references: Nat Rev Endocrinol. 2013 May;9(5):265-76
references: 23381030
references: J Biol Chem. 2001 Oct 19;276(42):39088-93
references: 11495927
references: Annu Rev Pharmacol Toxicol. 1994;34:117-33
references: 8042847
references: Endocr Metab Immune Disord Drug Targets. 2006 Mar;6(1):33-43
references: 16611163
references: Nature. 2007 Oct 11;449(7163):721-5
references: 17914358
references: J Lipid Res. 2007 Aug;48(8):1781-91
references: 17485727
references: Neurobiol Aging. 2009 Jul;30(7):1099-113
references: 18023506
references: Ann N Y Acad Sci. 2006 Nov;1083:306-18
references: 17148746
references: Acta Vet Scand Suppl. 1989;85:29-37
references: 2571275
references: Curr Drug Metab. 2012 Dec;13(10):1436-53
references: 22978398
references: Gene. 1996 May 8;170(2):165-71
references: 8666240
references: Antioxid Redox Signal. 2011 Feb 15;14(4):649-61
references: 20615072
references: Med Hypotheses. 2008;70(3):543-7
references: 17714881
references: Br J Exp Pathol. 1980 Jun;61(3):242-55
references: 7426380
references: Mol Cell Biol. 2007 Jun;27(12):4238-47
references: 17438130
references: Neurosci Biobehav Rev. 1992 Summer;16(2):115-30
references: 1630726
references: Pharmacol Rev. 1985 Sep;37(3):249-332
references: 2869509
references: J Biol Chem. 1996 Jan 19;271(3):1764-9
references: 8576180
references: Neuroimmunomodulation. 2009;16(5):300-17
references: 19571591
references: Curr Opin Investig Drugs. 2008 Mar;9(3):247-55
references: 18311660
references: Nutr Metab (Lond). 2005 Feb 02;2(1):3
references: 15689240
references: Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):39-46
references: 17717290
references: Mol Endocrinol. 2004 Jun;18(6):1321-32
references: 15087471
references: Hepatology. 1987 Nov-Dec;7(6):1189-94
references: 2824312
references: PLoS One. 2008 Feb 27;3(2):e1681
references: 18301758
references: Dose Response. 2009 Oct 13;8(1):64-7
references: 20221291
references: Exp Gerontol. 2003 Mar;38(3):267-78
references: 12581790
references: Nature. 2009 Apr 9;458(7239):757-61
references: 19194461
references: Cell. 2000 Sep 15;102(6):731-44
references: 11030617
references: Toxicol Appl Pharmacol. 2004 Sep 15;199(3):275-84
references: 15364543
references: J Biol Chem. 1991 Jun 15;266(17):11341-6
references: 2040638
references: Drugs Today (Barc). 2006 Jan;42(1):39-64
references: 16511610
references: J Lipid Res. 2007 Dec;48(12):2547-59
references: 17878492
references: J Clin Invest. 2004 Nov;114(10):1493-503
references: 15546000
references: J Biol Chem. 2006 Dec 29;281(52):40236-41
references: 17074755
references: J Clin Invest. 2012 Apr;122(4):1262-70
references: 22426206
references: J Clin Endocrinol Metab. 1998 Jun;83(6):1853-9
references: 9626108
references: J Gerontol. 1991 Jul;46(4):M108-13
references: 1649216
references: PPAR Res. 2009;2009:925309
references: 20052392
references: Prog Clin Biol Res. 1984;142:181-94
references: 6424133
references: Chem Biol Interact. 2004 Jan 15;147(1):65-77
references: 14726153
references: Atherosclerosis. 1996 Feb;120(1-2):135-45
references: 8645354
references: J Pediatr. 2008 Dec;153(6):839-44
references: 18657829
references: PLoS One. 2009;4(2):e4414
references: 19212441
references: J Biol Chem. 2008 Jun 13;283(24):16514-24
references: 18390901
references: Mol Med. 2008 Mar-Apr;14(3-4):195-204
references: 18079995
references: Endocrinology. 2008 Jun;149(6):2714-23
references: 18325986
references: Mol Genet Metab. 2003 Dec;80(4):398-407
references: 14654352
references: Mol Cell Biol. 2010 Feb;30(3):565-77
references: 19933841
references: Biochem Pharmacol. 2004 Jan 1;67(1):87-96
references: 14667931
references: Handb Exp Pharmacol. 2005;(170):389-406
references: 16596808
references: J Clin Endocrinol Metab. 1998 Jun;83(6):1842-5
references: 9626106
references: Adv Second Messenger Phosphoprotein Res. 1997;31:263-77
references: 9344257
references: Curr Opin Lipidol. 2011 Aug;22(4):270-6
references: 21519250
references: Biochim Biophys Acta. 2009 Jun;1791(6):494-500
references: 19010445
references: Nat Med. 2007 Feb;13(2):171-80
references: 17273170
references: Endocr J. 1996 Dec;43(6):645-55
references: 9075604
references: Curr Opin Lipidol. 2009 Jun;20(3):165-70
references: 19369868
references: Curr Diabetes Rev. 2007 Nov;3(4):252-9
references: 18220683
references: Nat Med. 2004 Apr;10(4):355-61
references: 15057233
references: Lipids Health Dis. 2010 Jan 14;9:4
references: 20070910
references: Metabolism. 2002 Jul;51(7):925-31
references: 12077743
references: Psychoneuroendocrinology. 2013 Sep;38(9):1698-708
references: 23490070
references: Biochem J. 2006 Jul 1;397(1):159-68
references: 16584384
references: Annu Rev Med. 1996;47:443-61
references: 8712794
references: Pharmacol Rev. 2006 Dec;58(4):726-41
references: 17132851
references: Endocrinology. 2008 Mar;149(3):942-9
references: 18202123
references: Curr Atheroscler Rep. 2007 Oct;9(4):274-80
references: 18173954
references: J Endocrinol Invest. 2008 May;31(5):406-15
references: 18560258